VAP Banner Image



National healthcare quality initiatives focusing on risk factors that contribute to ventilator-associated pneumonia (VAP) have drawn attention to the morbidity and mortality associated with this preventable hospital-acquired condition. Each year, an estimated 300,000 patients nationwide acquire VAP. Ventilator-associated pneumonia accounts for 60% of all deaths due to hospital-associated infections, and there is an increased cost of $40,000 - $50,000 per patient.

The MSC Ventilator-Associated Pneumonia (VAP) Quality Solution improves hospital performance in prevention and early identification of this costly infection. The VAP Quality Solution is authored by Brian Graham, MD, University of Colorado Hospital.
Subscribe now to MSC for updates!


MSC’s Ventilator-Associated Pneumonia Course educates clinicians on research-based guidelines surrounding the prevention and treatment of Ventilator-Associated Pneumonia per case. The course is designed for novice to advanced physicians, nurses, and respiratory therapists working in critical care areas of the hospital. This course also includes a hand-washing video to support the HAI preventative measure initiative.


Up to 28% of patients receiving mechanical ventilation develop pneumonia
Ventilator-associated pneumonia is associated with up to 30% mortality rate
VAP is associated with an increased cost of up to $25,000


Achieve and sustain compliance with CMS goal for zero VAP incidence, translating to improved clinical outcomes and reduced cost of care.
Improve hospital acquired infection (HAI) scores to achieve CMS incentives, avoid penalties and improve profitability.